<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="FeedCreator 1.8" -->
<?xml-stylesheet href="https://onwar.se/lib/exe/css.php?s=feed" type="text/css"?>
<rdf:RDF
    xmlns="http://purl.org/rss/1.0/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
    xmlns:dc="http://purl.org/dc/elements/1.1/">
    <channel rdf:about="https://onwar.se/feed.php">
        <title>Onwards - liraglutide_mechanism_of_action</title>
        <description></description>
        <link>https://onwar.se/</link>
        <image rdf:resource="https://onwar.se/lib/exe/fetch.php?media=wiki:dokuwiki.svg" />
       <dc:date>2026-09-30T20:13:06+00:00</dc:date>
        <items>
            <rdf:Seq>
                <rdf:li rdf:resource="https://onwar.se/doku.php?id=liraglutide_mechanism_of_action:for_weight_loss_and_diabetes&amp;rev=1790782750&amp;do=diff"/>
            </rdf:Seq>
        </items>
    </channel>
    <image rdf:about="https://onwar.se/lib/exe/fetch.php?media=wiki:dokuwiki.svg">
        <title>Onwards</title>
        <link>https://onwar.se/</link>
        <url>https://onwar.se/lib/exe/fetch.php?media=wiki:dokuwiki.svg</url>
    </image>
    <item rdf:about="https://onwar.se/doku.php?id=liraglutide_mechanism_of_action:for_weight_loss_and_diabetes&amp;rev=1790782750&amp;do=diff">
        <dc:format>text/html</dc:format>
        <dc:date>2026-09-30T15:39:10+00:00</dc:date>
        <dc:creator>Anonymous (anonymous@undisclosed.example.com)</dc:creator>
        <title>for_weight_loss_and_diabetes</title>
        <link>https://onwar.se/doku.php?id=liraglutide_mechanism_of_action:for_weight_loss_and_diabetes&amp;rev=1790782750&amp;do=diff</link>
        <description>Liraglutide mechanism of action for weight loss (obesity) and diabetes is detailed here. It belongs to the class of medicine called GLP-1 analogs and is available under the brand names Saxenda and Victoza. It is available as an injection for daily administration into the skin. The two main indications of the use of liraglutide are obesity and diabetes. Liraglutide is a long-acting analog of GLP-1 (Glucagon-like peptide). Glucagon-like peptides are also called incretins. GIP (Gastric inhibitory p…</description>
    </item>
</rdf:RDF>
